Ultra-Large Volume Wearable Injectors Market

SKU: DMMD2391 | Last Updated On: Nov 26 2021 | No. of Pages: 180 | Available Formats

> Global Ultra-Large Volume Wearable Injectors Market Expected to reach at a high CAGR 6.7% by 2028: DataM Intelligence

Global Ultra-Large Volume Wearable Injectors Market is segmented By Product Type (Electronic Wearable Injector, Mechanical Wearable Injectors, Others), By Application (Diabetes, Auto-immune Disease, Blood Disorders, Cancer, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2021-2028

 

Market Overview

The Global "Ultra-Large Volume Wearable Injectors Market" is expected to grow at a high CAGR 6.7% during the forecasting period (2021-2028).

The ultra-large volume wearable injectors are the medical devices used to deliver the large volume of drugs to the patients through the subcutaneous administration route by adhering to the body over a longer period of time. These devices allow the self-administration of the high-volume, high-viscosity drugs in a non-clinical setting. 

**Source: DataM Intelligence Analysis 

Market Dynamics:

The market growth is driven by the increasing prevalence of chronic diseases with the rising aging population as Chronic diseases are the leading cause of mortality and morbidity worldwide. According to the World Health Organization (WHO), the burden of chronic diseases is expected to reach 57% by 2020. Almost half of the deaths occurred due to cardiovascular diseases, obesity, and diabetes. The existing treatment available in the market for chronic diseases includes parenteral administration, frequent dosing, involve repeated hospital visits. This existing treatment increases the risk of developing microbial infection and needlestick injuries. It also impacts medication adherence. Hence, many companies are focusing on the development of advanced therapeutic delivery solutions for overcoming adverse events. This has led to the introduction of self-injected delivery solutions for drug administration beyond the clinical setting. This has resulted in reducing healthcare costs and improving drug adherence.

The market growth is influenced by the rising demand for ultra-large volume wearable injectors due to their advantages of providing convenient delivery in healthcare settings. There is growing adoption of ultra-large volume wearable injectors compared to the traditional infusion pump as ultra-large volume wearable injectors provide the larger volume drugs with higher viscosity within the 2 – 30 minutes. In contrast, the infusion pump performs drug infusions over hours or days. Moreover, the ultra-large volume wearable injectors are easy to use as these ultra-large volume wearable injectors have low injection frequency and need to wear the device.

 There is increasing research and development activities for the ultra-large volume wearable injectors. The novel ultra-large volume wearable injectors expected approvals should stimulate the market growth over the forecasted period. For instance, Becton, Dickinson, and Company are developing an ultra-large volume wearable injector, i.e., BD Libertas, for the self-administration of large volume and high viscosity drugs subcutaneously for the treatment of various chronic diseases over longer periods of time. It is a pre-filled, pre-assembled injector is designed to prioritize safety, convenience, and usability, while delivering high-value drug treatments in the comfort of an in-home environment.

The subject is developing the Subject Wearable Bolus Injector (WBI) that provides a longer delivery time for larger, viscous doses than auto-injectors. It allows the self-administration of large doses over a pre-defined delivery period to avoid injection site leakage, local intolerability, injection pain, etc. It injects the drugs with high viscosities and Accommodates high dose volumes (1-10 ml). It would provide the Simple (one button) activation and noiseless operation. It automatically inserts the needle at activation and retracts the needle after completion.

Segment Analysis

The ultra-large volume wearable injectors market is segmented based on product type as electromechanical wearable injectors, mechanical wearable injectors, etc. The electromechanical wearable injectors segment accounts for the highest market share of XX% in 2018. The electromechanical ultra-large volume wearable injectors deliver the drug by building the pressure with an electrical motor's help. The electromechanical devices deliver medication at a constant delivery instead of tissue back-pressure. There is an increase in the number of companies developing electromechanical ultra-large volume wearable injectors. For instance, YpsoDose is a single-use ultra-large volume wearable injector under the development by Ypsomed Holding AG. It is an electromechanical pre-filled and pre-assembled patch device for 10 ml glass cartridges. It is patched directly to the skin with an integrated pre-filled drug reservoir, sterile fluid path, and needle system. It has a unique programmable electromechanical drive system for a range of viscosities and fills volumes. It is effective in performing the needle insertion, injection, end of injection feedback, and needle safety steps automatically. It is comprised of customizable device housing shells to provide customer-specific device designs.

The mechanical wearable injectors segment is expected to have positive market growth due to the mechanical ultra-large volume wearable injectors' ability to reduce risk and increase reliability. The mechanical wearable injectors provide more comfortable injections than the electromechanical wearable injectors as these injectors are responsive to tissue back-pressure.

Further, the market is also classified based on diabetes, auto-immune disease, blood disorders, cancer, etc. The diabetes segment accounts for the highest market share of XX% in 2019. The prevalence of diabetes is increasing with the rise in the aging population. According to the International Diabetes Federation (IDF), approximately 463 million adults of age-group 20-79 have Diabetes worldwide and are expected to increase and reach up to 700 million by 2045. More than 1.1 million children and adolescents are living with type 1 diabetes worldwide. Around 374 million people are at increased risk of developing type 2 diabetes. The introduction of the ultra-large volume wearable injectors overcome the limitations of the existing treatment for diabetes, including the difficulty in tracking the frequency of doses, leading to two missed doses or even double doses, fear of needles, and painful injections. The ultra-large volume wearable injectors allow the tracking and sharing of the injection data to improve adherence and therapy outcomes among patients with diabetes. These wearable injectors provide comfort, convenience, and discreetness in improving the patient's quality of life.

**Source: DataM Intelligence Analysis

Geographical Presentation

By region, the ultra-large volume wearable injectors market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Among all of the regions, North America dominated the ultra-large volume wearable injectors market due to the large number of biologics suited for delivery via self-administered injection that is approved or under development to treat chronic conditions require frequent dosing. The high prevalence of chronic disease shall stimulate market growth. According to the Centers for Disease Control and Prevention (CDC), around 6 in 10 people are affected by one chronic disease. Approximately 4 in 10 people are suffering from two or more chronic diseases. The United States is expected to have the highest market share of XX% in 2019. The ease of availability of ultra-large volume wearable injectors and high healthcare expenditure to improve healthcare facilities will fuel market growth. The North America region is expected to maintain its dominant position over the forecasted period.

The Asia Pacific region is expected to have positive market growth due to increasing awareness regarding the advantages of ultra-large volume wearable injectors for drug administration. Patient self-administration of subcutaneous injections is expected to save approximately 30% to 70% of costs. Thus, it provides lucrative opportunities for market players. The rising research and development activities for ultra-large volume wearable injectors,s especially in China, Australia, and Japan, will positively impact the market. The demand for ultra-large volume wearable injectors is expected to increase with the increasing per-capita healthcare, domestic income, purchasing power, and healthcare expenditure over the forecasted period.

**Source: DataM Intelligence Analysis

Competitive Analysis

The ultra-large volume wearable injectors market is highly competitive with the presence of several international and local markets. Product development, technological advancement, and opportunities intensify the market competition. Becton, Dickinson and Company, Ypsomed Holding AG, Enable Injections, Inc., Medtronic Plc., Amgen Inc., and Sensile Medical AG (Gerresheimer AG) are the leading market players with significant market share.

Companies have increased their research and development activities for ultra-large volume wearable injectors. For instance, in February 2020, Becton, Dickinson, and Company had completed the 50-subject human clinical trial with the BD Libertas Wearable Injector. This study was conducted to examine the performance of the 5 mL BD Libertas device in human subjects, including tissue effects, skin reactivity, and patient acceptance. In March 2019, Becton, Dickinson, and Company had won the Good Design Award for the BD Libertas Wearable Injector. Moreover, the company had also received the iF Award for its BD Libertas Wearable Injector.

The companies enter into collaborations, mergers, strategic partnerships, and acquisitions to increase the demand for ultra-large volume wearable injectors Market and their expansion across the globe. For instance, in July 2018, Gerresheimer has acquired Sensile Medical. Under the terms of the agreement, Sensile Medical would become part of the Gerresheimer. Gerresheimer’s extensive range of primary packaging for parenteral would be valuable in developing device and delivery systems.

Why Purchase the Report?

  • Visualize the composition of the ultra-large volume wearable injectors market products in terms of product type and applications highlighting the critical commercial assets and players.
  • Identify commercial opportunities in the ultra-large volume wearable injectors market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of ultra-large volume wearable injectors market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

**The global ultra-large volume wearable injectors market report will provide access to approximately 53 market data tables, 44 figures, and 178 pages

Target Audience

  • Industry Investors/Investment Bankers
  • Suppliers/Buyers
  • Education & Research Institutes
  • Manufacturers
  • Research Professionals
  • Emerging Companies
  • Distributors

Trending Topics

Wearable Heart Monitoring Devices Market

Wearable Medical Devices Market

 

Table of Contents 

  1. Ultra-Large Volume Wearable Injectors Market Methodology and Scope

    1. Research Methodology
    2. Research Objective and Scope of the Report
  2. Ultra-Large Volume Wearable Injectors Market – Market Definition and Overview

  3. Ultra-Large Volume Wearable Injectors Market – Executive Summary

    1. Market Snippet By Product Type
    2. Market Snippet By Application
    3. Market Snippet by Region
  4. Ultra-Large Volume Wearable Injectors Market Dynamics

    1. Market Impacting Factors
      1. Drivers
      2.  Restraints
      3. Impact Analysis
      4. Opportunity
  5. Ultra-Large Volume Wearable Injectors Market – Industry Analysis

    1. Porter's Five Forces Analysis
    2. Supply Chain Analysis
    3. Regulatory Analysis
    4. Pricing Analysis
  6. Ultra-Large Volume Wearable Injectors Market – By Product Type

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      2. Market Attractiveness Index, By Product Type
    2. Electronic Wearable Injectors*
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028
    3. Mechanical Wearable Injectors
    4. Others
  7. Ultra-Large Volume Wearable Injectors Market – By Application

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      2. Market Attractiveness Index, By Application
    2. Diabetes*
      1. Introduction
      2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2028
    3. Auto-immune Disease
    4. Blood Disorders
    5. Cancer
    6. Others
  8. Ultra-Large Volume Wearable Injectors Market - By Region

    1. Introduction
      1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
      2. Market Attractiveness Index, By Region
    2. North America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. The U.S.
        2. Canada
        3. Mexico
    3. Europe
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Germany
        2. The U.K.
        3. France
        4. Rest of Europe
    4. South America
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
        1. Brazil
        2. Argentina
        3. Rest of South America
    5. Asia Pacific
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
      5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

        1. China
        2. India
        3. Japan
        4. Australia
        5. Rest of Asia Pacific
    6. The Middle East and Africa
      1. Introduction
      2. Key Region-Specific Dynamics
      3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
      4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
  9. Ultra-Large Volume Wearable Injectors Market Competitive Landscape

    1. Competitive Scenario
    2. Market Positioning/Share Analysis
    3. Mergers and Acquisitions Analysis
  10. Ultra-Large Volume Wearable Injectors Market Company Profiles

    1. Becton, Dickinson, and Company*
      1. Company Overview
      2. Form Portfolio and Description
      3. Key Highlights
      4. Financial Overview
    2. Insulet Corporation
    3. Tandem Diabetes Care, Inc.
    4. Ypsomed Holding Ag
    5. Enable Injections, Inc.
    6. Medtronic Plc.
    7. Amgen Inc.
    8. Sensile Medical AG (Gerresheimer AG)
    9. West Pharmaceutical Services, Inc.
    10. Cequr SA (*List is not exhaustive)
  11. Ultra-Large Volume Wearable Injectors Market – Premium Insights

  12. Ultra-Large Volume Wearable Injectors Market – DataM

    1. Appendix
    2. About Us and Services
    3. Contact Us

 

List of Tables & Figures

List of Tables 

Table 01 Global Ultra-Large Volume Wearable Injectors Market Value, By Product Type, 2018,2022 & 2028 ($ Million)

Table 02 Global Ultra-Large Volume Wearable Injectors Market Value, By Application, 2018,2022 & 2028 ($ Million)

Table 03 Global Ultra-Large Volume Wearable Injectors Market Value, By Region, 2018,2022 & 2028 ($ Million)

Table 04 Global Ultra-Large Volume Wearable Injectors Market Value, By Product Type, 2018,2022 & 2028 ($ Million)

Table 05 Global Ultra-Large Volume Wearable Injectors Market Value, By Product Type, 2017-2028 ($ Million)

Table 06 Global Ultra-Large Volume Wearable Injectors Market Value, By Application, 2018,2022 & 2028 ($ Million)

Table 07 Global Ultra-Large Volume Wearable Injectors Market Value, By Application, 2017-2028 ($ Million)

Table 09 Global Ultra-Large Volume Wearable Injectors Market Value, By Region, 2018,2022 & 2028 ($ Million)

Table 10 Global Ultra-Large Volume Wearable Injectors Market Value, By Region, 2017-2028 ($ Million)

Table 11 North America Ultra-Large Volume Wearable Injectors Market Value, By Product Type, 2017-2028 ($ Million)

Table 12 North America Ultra-Large Volume Wearable Injectors Market Value, By Application, 2017-2028 ($ Million)

Table 13 North America Ultra-Large Volume Wearable Injectors Market Value, By Country, 2017-2028 ($ Million)

Table 14 South America Ultra-Large Volume Wearable Injectors Market Value, By Product Type, 2017-2028 ($ Million)

Table 15 South America Ultra-Large Volume Wearable Injectors Market Value, By Application, 2017-2028 ($ Million)

Table 16 South America Ultra-Large Volume Wearable Injectors Market Value, By Country, 2017-2028 ($ Million)

Table 17 Europe Ultra-Large Volume Wearable Injectors Market Value, By Product Type, 2017-2028 ($ Million)

Table 18 Europe Ultra-Large Volume Wearable Injectors Market Value, By Application, 2017-2028 ($ Million)

Table 19 Europe Ultra-Large Volume Wearable Injectors Market Value, By Country, 2017-2028 ($ Million)

Table 20 Asia-Pacific Ultra-Large Volume Wearable Injectors Market Value, By Product Type, 2017-2028 ($ Million)

Table 21 Asia-Pacific Ultra-Large Volume Wearable Injectors Market Value, By Application, 2017-2028 ($ Million)

Table 22 Asia-Pacific Ultra-Large Volume Wearable Injectors Market Value, By Country, 2017-2028 ($ Million)

Table 23 Middle East & Africa Ultra-Large Volume Wearable Injectors Market Value, By Product Type, 2017-2028 ($ Million)

Table 24 Middle East & Africa Ultra-Large Volume Wearable Injectors Market Value, By Application, 2017-2028 ($ Million)

Table 25 Becton, Dickinson and Company: Overview

Table 26 Becton, Dickinson and Company: Product Portfolio

Table 27 Becton, Dickinson and Company: Key Developments

Table 28 Insulet Corporation: Overview

Table 29 Insulet Corporation: Product Portfolio

Table 30 Insulet Corporation: Key Developments

Table 31 Tandem Diabetes Care, Inc.: Overview

Table 32 Tandem Diabetes Care, Inc.: Product Portfolio

Table 33 Tandem Diabetes Care, Inc.: Key Developments

Table 34 Ypsomed Holding AG: Overview

Table 35 Ypsomed Holding AG: Product Portfolio

Table 36 Ypsomed Holding AG: Key Developments

Table 37 Enable Injections, Inc.: Overview

Table 38 Enable Injections, Inc.: Product Portfolio

Table 39 Enable Injections, Inc.: Key Developments

Table 40 Medtronic Plc.: Overview

Table 41 Medtronic Plc.: Product Portfolio

Table 42 Medtronic Plc.: Key Developments

Table 43 Amgen Inc.: Overview

Table 44 Amgen Inc.: Product Portfolio

Table 45 Amgen Inc.: Key Developments

Table 46 Sensile Medical AG (Gerresheimer AG): Overview

Table 47 Sensile Medical AG (Gerresheimer AG): Product Portfolio

Table 48 Sensile Medical AG (Gerresheimer AG): Key Developments

Table 49 West Pharmaceutical Services, Inc.: Overview

Table 50 West Pharmaceutical Services, Inc.: Product Portfolio

Table 51 West Pharmaceutical Services, Inc.: Key Developments

Table 52 Cequr SA: Overview

Table 53 Cequr SA: Product Portfolio

Table 54 Cequr SA: Key Developments

 

List of Figures

Figure 01 Global Ultra-Large Volume Wearable Injectors Market Share, By Product Type, 2018 & 2028 (%)

Figure 02 Global Ultra-Large Volume Wearable Injectors Market Share, By Application, 2018 & 2028 (%)

Figure 03 Global Ultra-Large Volume Wearable Injectors Market Share, By Region, 2018 & 2028 (%)

Figure 04 Global Ultra-Large Volume Wearable Injectors Market Value, 2017-2028 ($ Million)

Figure 05 Global Ultra-Large Volume Wearable Injectors Market Y-o-Y Growth, By Product Type, 2018-2028 (%)

Figure 06 Electronical Wearable Injectors: Global Ultra-Large Volume Wearable Injectors Market Value, 2017-2028 ($ Million)

Figure 07 Mechanical Wearable Injectors: Global Ultra-Large Volume Wearable Injectors Market Value, 2017-2028 ($ Million)

Figure 08 Others: Global Ultra-Large Volume Wearable Injectors Market Value, 2017-2028 ($ Million)

Figure 09 Global Ultra-Large Volume Wearable Injectors Market Y-o-Y Growth, By Application, 2018-2028 (%)

Figure 10 Diabetes: Global Ultra-Large Volume Wearable Injectors Market Value, 2017-2028 ($ Million)

Figure 11 Auto-immune Disease: Global Ultra-Large Volume Wearable Injectors Market Value, 2017-2028 ($ Million)

Figure 12 Blood Disorders: Global Ultra-Large Volume Wearable Injectors Market Value, 2017-2028 ($ Million)

Figure 13 Cancers: Global Ultra-Large Volume Wearable Injectors Market Value, 2017-2028 ($ Million)

Figure 14 Others: Global Ultra-Large Volume Wearable Injectors Market Value, 2017-2028 ($ Million)

Figure 15 Global Ultra-Large Volume Wearable Injectors Market Y-o-Y Growth, By Region, 2018-2028 (%)

Figure 16 North America Ultra-Large Volume Wearable Injectors Market Value, 2017-2028 ($ Million)

Figure 17 North America Ultra-Large Volume Wearable Injectors Market Share, By Product Type, 2018 & 2028 (%)

Figure 18 North America Ultra-Large Volume Wearable Injectors Market Share, By Application, 2018 & 2028 (%)

Figure 19 North America Ultra-Large Volume Wearable Injectors Market Share, By Country, 2018 & 2028 (%)

Figure 20 South America Ultra-Large Volume Wearable Injectors Market Value, 2017-2028 ($ Million)

Figure 21 South America Ultra-Large Volume Wearable Injectors Market Share, By Product Type, 2018 & 2028 (%)

Figure 22 South America Ultra-Large Volume Wearable Injectors Market Share, By Application, 2018 & 2028 (%)

Figure 23 South America Ultra-Large Volume Wearable Injectors Market Share, By Country, 2018 & 2028 (%)

Figure 24 Europe Ultra-Large Volume Wearable Injectors Market Value, 2017-2028 ($ Million)

Figure 25 Europe Ultra-Large Volume Wearable Injectors Market Share, By Product Type, 2018 & 2028 (%)

Figure 26 Europe Ultra-Large Volume Wearable Injectors Market Share, By Application, 2018 & 2028 (%)

Figure 27 Europe Ultra-Large Volume Wearable Injectors Market Share, By Country, 2018 & 2028 (%)

Figure 28 Asia-Pacific Ultra-Large Volume Wearable Injectors Market Value, 2017-2028 ($ Million)

Figure 29 Asia-Pacific Ultra-Large Volume Wearable Injectors Market Share, By Product Type, 2018 & 2028 (%)

Figure 30 Asia-Pacific Ultra-Large Volume Wearable Injectors Market Share, By Application, 2018 & 2028 (%)

Figure 31 Asia-Pacific Ultra-Large Volume Wearable Injectors Market Share, By Country, 2018 & 2028 (%)

Figure 32 the Middle East & Africa Ultra-Large Volume Wearable Injectors Market Value, 2017-2028 ($ Million)

Figure 33 the Middle East & Africa Ultra-Large Volume Wearable Injectors Market Share, By Product Type 2018 & 2028 (%)

Figure 34 the Middle East & Africa Ultra-Large Volume Wearable Injectors Market Share, By Application, 2018 & 2028 (%)

Figure 35 Becton, Dickinson And Company: Financials

Figure 36 Insulet Corporation: Financials

Figure 37 Tandem Diabetes Care, Inc.: Financials

Figure 38 Ypsomed Holding AG: Financials

Figure 39 Enable Injections, Inc.: Financials

Figure 40 Medtronic PLC.: Financials

Figure 41 Amgen Inc.: Financials

Figure 42 Sensile Medical AG (Gerresheimer AG): Financials

Figure 43 West Pharmaceutical Services, Inc.: Financials

Figure 44 Cequr SA: Financials

 

Did not find what you were looking for?Every 7 out of 10 customers request tailored reports. Get yours today!
We collate your requirements.
Our global research team is put into action.
We deliver, and make sure your endeavour is a success!

Buy This Report

20% Discount Applied*



Year-End Offer from
DataM Intelligence

Note*: For "Bundle/Bulk" Subscription of Reports,
please contact: [email protected]

Get your free sample proposal with a single click!

linkedinpinterest